Genome Editing Market

Genome Editing Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 180

To learn more about this report, request a free sample copy

Genome Editing Market Overview

The report is titled ‘Genome Editing Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Genome Editing market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Genome editing market is expected to grow at a significant rate in the near future.

The global genome editing market in 2020 is estimated for more than US$ 2.4 Bn and expected to reach a value of US$ 14.5 Bn by 2028 with a significant CAGR of 25.3%.

Genome Editing Introduction

Genome editing is a method of making definite variations to the DNA of an organism or cell. The method of genome editing involves cutting the particular DNA sequence with an engineered nucleus, more commonly known as an enzyme.

The main purpose of genome editing is to add, cut down, or amend DNA in the genome that results in changes in the features of an organism or cell. The method of genome editing can be applied to any kind of organism to alter the DNA in the genome,

However, it is wrongful and prohibited to practice genome editing on human embryos. Although genome editing finds applications in numerous industries such as in biotechnology, for research and development activities as well as it can promote its utility in treating some severe diseases. Thus, the genome editing market is expected to observe substantial growth in the near future.

Genome Editing Market Dynamics

The increased research and development activities these days are majorly contributing to the growth of the global genome editing market, as genome editing serves its utility in altering the DNA in organisms or cells in order to get the picture of their biology and their work. Along with that, genomic editing also serves in treating various chronic diseases such as AIDS, leukemia, MRSA, hemophilia, muscular dystrophy, and many more as it carries the potential to customize the human blood cells that are then put back into the body.

Owing to this, the global genome editing market is expected to witness significant growth in the forthcoming future By the same token, the employment of the method in the accomplishment of therapeutic genome editing in contaminated or affected tissues or cells, thereby eliminating the harmful variation is also expected to give a positive boost to the growth of the global genome editing market in the near future.

In addition to that, the soaring count of partnerships, collaborations, and acquisitions in biotechnological and pharmaceutical companies in the present-day world is also contributing to the growing number of research activities, thus increasing the applications for genome editing in the upcoming future. Thus, the global genome editing market is projected to elevate positively during the forecast timeframe.

Genome Editing Market Key Players

Some of the key participating players in the genome editing market are

Thermo Fisher Scientific

Merck

Horizon Discovery Group

Genscript

Sangamo Biosciences

Integrated DNA Technologies

Lonza

New England Biolabs

Origene Technologies

Transposagen Biopharmaceuticals

Editas Medicine

Crispr Therapeutics

Genome Editing Market Segmentation

The global genome editing market is segmented on the basis of technology, application, end-user, and region.

By Technology

CRISPR

TALEN

ZFN

Antisense

Other Technologies

By Application

Cell line Engineering

Genetic Engineering

Other Applications

By End-User

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

MMC Overview on Genome Editing Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the genome editing market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Genome Editing

•    Advantage of Genome Editing

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights into the product segment in the report. This helps our clients to make an informed decision.

A mix of top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Genome Editing Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Genome Editing Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Genome Editing Market Snapshot

2.4.    Global Genome Editing Market Size and Forecast, 2019–2027

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5.    Global Genome Editing Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Genome Editing Market, By Technology

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Technology

3.1.2.    BPS Analysis, By Technology

3.2.    Market Revenue (US$Mn) Forecast, By Technology

3.2.1.    CRISPR

3.2.2.    TALEN

3.2.3.    ZFN

3.2.4.    Antisense

3.2.5.    Other technologies

3.3.    Global Genome Editing Market Attractiveness Index, By Technology

4.    Global Genome Editing Market, By Application

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Application

4.1.2.    BPS Analysis, By Application

4.2.    Market Revenue (US$Mn) Forecast, By Application

4.2.1.    Cell line Engineering

4.2.2.    Genetic Engineering

4.2.3.    Other Applications

4.3.    Global Genome Editing Market Attractiveness Index, By Application

5.    Global Genome Editing Market, By End User

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By End User

5.1.2.    BPS Analysis, By End User

5.2.    Market Revenue (US$Mn) Forecast, By End User

5.2.1.    Pharmaceutical & Biotechnology Companies

5.2.2.    Academic & Research Institutes

5.2.3.    Contract Research Organizations

5.3.    Global Genome Editing Market Attractiveness Index, By End User

6.    Global Genome Editing Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Genome Editing Market Attractiveness Index, By Region

7.    North America Genome Editing Market Analysis and Forecast, 2019–2027

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Genome Editing Market

7.2.2.    Canada Genome Editing Market

7.3.    North America Genome Editing Market, By Technology

7.3.1.    CRISPR

7.3.2.    TALEN

7.3.3.    ZFN

7.3.4.    Antisense

7.3.5.    Other technologies

7.4.    North America Genome Editing Market, By Application

7.4.1.    Cell line Engineering

7.4.2.    Genetic Engineering

7.4.3.    Other Applications

7.5.    North America Genome Editing Market, By End User

7.5.1.    Pharmaceutical & Biotechnology Companies

7.5.2.    Academic & Research Institutes

7.5.3.    Contract Research Organizations

7.6.    North America Genome Editing Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Technology

7.6.3.    By Application

7.6.4.    By End User

8.    Latin America Genome Editing Market Analysis and Forecast, 2019–2027

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Genome Editing Market

8.2.2.    Mexico Genome Editing Market

8.2.3.    Argentina Genome Editing Market

8.2.4.    Rest of Latin America Genome Editing Market

8.3.    Latin America Genome Editing Market, By Technology

8.3.1.    CRISPR

8.3.2.    TALEN

8.3.3.    ZFN

8.3.4.    Antisense

8.3.5.    Other technologies

8.4.    Latin America Genome Editing Market, By Application

8.4.1.    Cell line Engineering

8.4.2.    Genetic Engineering

8.4.3.    Other Applications

8.5.    Latin America Genome Editing Market, By End User

8.5.1.    Pharmaceutical & Biotechnology Companies

8.5.2.    Academic & Research Institutes

8.5.3.    Contract Research Organizations

8.6.    Latin America Genome Editing Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Technology

8.6.3.    By Application

8.6.4.    By End User

9.    Europe Genome Editing Market Analysis and Forecast, 2019–2027

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Genome Editing Market

9.2.2.    Germany Genome Editing Market

9.2.3.    Italy Genome Editing Market

9.2.4.    France Genome Editing Market

9.2.5.    Spain Genome Editing Market

9.2.6.    Russia Genome Editing Market

9.2.7.    Poland Genome Editing Market

9.2.8.    BENELUX Genome Editing Market

9.2.9.    NORDIC Genome Editing Market

9.2.10.    Rest of Europe Genome Editing Market

9.3.    Europe Genome Editing Market, By Technology

9.3.1.    CRISPR

9.3.2.    TALEN

9.3.3.    ZFN

9.3.4.    Antisense

9.3.5.    Other technologies

9.4.    Europe Genome Editing Market, By Application

9.4.1.    Cell line Engineering

9.4.2.    Genetic Engineering

9.4.3.    Other Applications

9.5.    Europe Genome Editing Market, By End User

9.5.1.    Pharmaceutical & Biotechnology Companies

9.5.2.    Academic & Research Institutes

9.5.3.    Contract Research Organizations

9.6.    Europe Genome Editing Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Technology

9.6.3.    By Application

9.6.4.    By End User

10.    Asia Pacific Genome Editing Market Analysis and Forecast, 2019–2027

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Genome Editing Market

10.2.2.    India Genome Editing Market

10.2.3.    Japan Genome Editing Market

10.2.4.    Australia and New Zealand Genome Editing Market

10.2.5.    South Korea Genome Editing Market

10.2.6.    ASEAN Genome Editing Market

10.2.7.    Rest of Asia Pacific Genome Editing Market

10.3.    Asia Pacific Genome Editing Market, By Technology

10.3.1.    CRISPR

10.3.2.    TALEN

10.3.3.    ZFN

10.3.4.    Antisense

10.3.5.    Other technologies

10.4.    Asia Pacific Genome Editing Market, By Application

10.4.1.    Cell line Engineering

10.4.2.    Genetic Engineering

10.4.3.    Other Applications

10.5.    Asia Pacific Genome Editing Market, By End User

10.5.1.    Pharmaceutical & Biotechnology Companies

10.5.2.    Academic & Research Institutes

10.5.3.    Contract Research Organizations

10.6.    Asia Pacific Genome Editing Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Technology

10.6.3.    By Application

10.6.4.    By End User

11.    Middle East Genome Editing Market Analysis and Forecast, 2019–2027

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Genome Editing Market

11.2.2.    Israel Genome Editing Market

11.2.3.    Oman Genome Editing Market

11.2.4.    Rest of Middle East Genome Editing Market

11.3.    Middle East Genome Editing Market, By Technology

11.3.1.    CRISPR

11.3.2.    TALEN

11.3.3.    ZFN

11.3.4.    Antisense

11.3.5.    Other technologies

11.4.    Middle East Genome Editing Market, By Application

11.4.1.    Cell line Engineering

11.4.2.    Genetic Engineering

11.4.3.    Other Applications

11.5.    Middle East Genome Editing Market, By End User

11.5.1.    Pharmaceutical & Biotechnology Companies

11.5.2.    Academic & Research Institutes

11.5.3.    Contract Research Organizations

11.6.    Middle East Genome Editing Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Technology

11.6.3.    By Application

11.6.4.    By End User

12.    Africa Genome Editing Market Analysis and Forecast, 2019–2027

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Genome Editing Market

12.2.2.    Egypt Genome Editing Market

12.2.3.    North Africa Genome Editing Market

12.2.4.    Rest of Africa Genome Editing Market

12.3.    Africa Genome Editing Market, By Technology

12.3.1.    CRISPR

12.3.2.    TALEN

12.3.3.    ZFN

12.3.4.    Antisense

12.3.5.    Other technologies

12.4.    Africa Genome Editing Market, By Application

12.4.1.    Cell line Engineering

12.4.2.    Genetic Engineering

12.4.3.    Other Applications

12.5.    Africa Genome Editing Market, By End User

12.5.1.    Pharmaceutical & Biotechnology Companies

12.5.2.    Academic & Research Institutes

12.5.3.    Contract Research Organizations

12.6.    Africa Genome Editing Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Technology

12.6.3.    By Application

12.6.4.    By End User

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Thermo Fisher Scientific

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Technology Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Merck

14.3.3.     Horizon Discovery Group

14.3.4.     Genscript

14.3.5.     Sangamo Biosciences

14.3.6.     Integrated Dna Technologies

14.3.7.     Lonza

14.3.8.     New England Biolabs

14.3.9.     Origene Technologies

14.3.10.     Transposagen Biopharmaceuticals

14.3.11.     Editas Medicine

14.3.12.     Crispr Therapeutics

15.    Acronyms

          Thermo Fisher Scientific

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Merck

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Horizon Discovery Group

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Genscript

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Sangamo Biosciences

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Integrated Dna Technologies

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Lonza

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         New England Biolabs

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Origene Technologies

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Transposagen Biopharmaceuticals

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Editas Medicine

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

         Crispr Therapeutics

•    Company Overview

•    Financial Overview

•    Product Portfolio

•    Key Developments

•    Business Strategies

Select License Type

Frequently Asked Questions

The global genome editing market in 2020 is estimated for more than US$ 2.4 Bn and expected to reach a value of US$ 14.5 Bn by 2028 with a significant CAGR of 25.3%.

The increased research and development activities. Also, genomic editing also serves in treating various chronic diseases such as AIDS, leukemia, MRSA, hemophilia, muscular dystrophy, and many more as it carries the potential to customize the human blood cells that are then put back into the body.

The global genome editing market is segmented on the basis of technology, application, end-user, and region.

Some of the key participating players in the genome editing market are Thermo Fisher Scientific, Merck, Horizon Discovery Group, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, and Crispr Therapeutics



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK